Harrow, Inc. Derivative, Variable Interest Rate
Harrow, Inc. (HROW) had Derivative, Variable Interest Rate of 0.72% as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes
us-gaap:DerivativeVariableInterestRate · last filed 2022-03-10
- 2021-12-31: Derivative, Variable Interest Rate 0.72%.
- 2021-09-30: Derivative, Variable Interest Rate 0.72%.
| Period end | Derivative, Variable Interest Rate |
|---|---|
| 2021-12-31 | 0.72% 10-K · filed 2022-03-10 |
| 2021-09-30 | 0.72% 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |